Renin Inhibition by Aliskiren Prevents Atherosclerosis Progression: Comparison With Irbesartan, Atenolol, and Amlodipine

Hypertension - United States
doi 10.1161/hypertensionaha.108.110932
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Direct Renin Inhibition: Focus on Aliskiren

Journal of Managed Care Pharmacy
2007English

Effects of the Direct Renin Inhibitor Aliskiren and Atenolol Alone or in Combination in Patients With Hypertension1

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System
Internal MedicineEndocrinology
2008English

Aliskiren Improves Nitric Oxide Bioavailability and Limits Atherosclerosis

Hypertension
Internal Medicine
2008English

Sevelamer Prevents Uremia-Enhanced Atherosclerosis Progression in Apolipoprotein E-Deficient Mice

Circulation
Cardiovascular MedicinePhysiologyCardiology
2005English

Simultaneous Estimation of Aliskiren and Amlodipine in Combined Tablet Formulation by Simultaneous Equation and First Derivative Spectroscopic Methods

Organic & Medicinal Chemistry International Journal
2018English

Combined Aliskiren-Amlodipine Treatment for Hypertension in African Americans: Clinical Science and Management Issues

Therapeutic Advances in Cardiovascular Disease
Cardiovascular MedicinePharmacologyCardiology
2011English

Inhibition of Ileal Na+/Bile Acid Cotransporter by S-8921 Reduces Serum Cholesterol and Prevents Atherosclerosis in Rabbits

Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular MedicineCardiology
1998English

Inhibition of the Renin–angiotensin System Prevents Seizures in a Rat Model of Epilepsy

Clinical Science
Medicine
2010English

Evaluation of Amlodipine Inhibition and Antimicrobial Effects

International Journal of Pharmacy and Chemistry
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy